Literature DB >> 22753258

Synthesis and molecular modeling studies of derivatives of a highly potent peptidomimetic vinyl ester as falcipain-2 inhibitors.

Roberta Ettari1, Nicola Micale, Giovanni Grazioso, Floriana Bova, Tanja Schirmeister, Silvana Grasso, Maria Zappalà.   

Abstract

Herein we report the synthesis of a set of constrained peptidomimetics endowed with an electrophilic vinyl ester warhead and structurally related to a previously identified lead compound, a potent and irreversible inhibitor of falcipain-2 (FP-2). FP-2 is the main hemoglobinase of the malaria parasite P. falciparum. The new compounds were evaluated for their inhibition against FP-2, and the results were rationalized on the basis of docking experiments. These studies underscore the pivotal role of both the ester function at the P1' site and the trifluoromethyl group of the P3 side chain in determining the correct orientation of the Michael acceptor warhead in the catalytic site, and as a consequence, the potency of the inhibitors as well as their reversible or irreversible mode of inhibition.
Copyright © 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22753258     DOI: 10.1002/cmdc.201200274

Source DB:  PubMed          Journal:  ChemMedChem        ISSN: 1860-7179            Impact factor:   3.466


  2 in total

1.  Structure-based drug design, synthesis and biological assays of P. falciparum Atg3-Atg8 protein-protein interaction inhibitors.

Authors:  Stefania Villa; Laura Legnani; Diego Colombo; Arianna Gelain; Carmen Lammi; Daniele Bongiorno; Denise P Ilboudo; Kellen E McGee; Jürgen Bosch; Giovanni Grazioso
Journal:  J Comput Aided Mol Des       Date:  2018-01-30       Impact factor: 3.686

2.  Drug Synergism: Studies of Combination of RK-52 and Curcumin against Rhodesain of Trypanosoma brucei rhodesiense.

Authors:  Roberta Ettari; Santo Previti; Carla Di Chio; Santina Maiorana; Alessandro Allegra; Tanja Schirmeister; Maria Zappalà
Journal:  ACS Med Chem Lett       Date:  2020-01-15       Impact factor: 4.345

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.